Discover key insights and essential strategies for managing the legal intricacies involved in pioneering advancements within the life sciences sector. Equip yourself with the essential tools to navigate regulatory frameworks, protect intellectual property, and ensure compliance during each phase of research and development. Enhance your practice with practical, actionable guidance tailored for legal professionals driving innovation in the rapidly evolving life sciences landscape.
The following Life Sciences news provides comprehensive and up to date legal information on Life Sciences weekly highlights—15 May 2025
The regulation of medical devices in the UKThis Practice Note provides an overview of the UK regulatory regime for medical devices. It explains the...
Regulation of e-cigarettes31 December 2020 marked the end of the Brexit implementation period following the UK’s decision to withdraw from the EU. At...
Clinical evaluation and performance evaluation of medical devices in the EUThis Practice Note describes key changes to the requisite clinical...
Unlicensed medicinal products and off-label use of medicinal productsThis Practice Note explores unlicensed medicinal products and the various ways...
Clinical trials in the UKSTOP PRESS—Impact of the Retained EU Law (Revocation and Reform) Act 2023: This document contains references to retained EU law (REUL) and associated terms introduced by the European Union (Withdrawal) Act 2018 in connection with Brexit. From 1 January 2024, REUL that
Introduction to technology transfer agreements in the Life Sciences industrySTOP PRESS—Impact of the Retained EU Law (Revocation and Reform) Act 2023: This document contains references to retained EU law (REUL) and associated terms introduced by the European Union (Withdrawal) Act 2018 in connection
Life Sciences analysis: Ross Cummings, partner, and Kessia Hawkins, associate, at Gill Jennings & Every LLP, discuss the Medicines and Healthcare products Regulatory Agency’s (MHRA) approval of CASGEVY, the world’s first CRISPR-based gene therapy as well as the first gene therapy for the
Early leavers—preservationFORTHCOMING DEVELOPMENT: Section 10 of the Finance Act 2022 will increase the normal minimum pension age (NMPA) from 55 to 57 on 6 April 2028 (save for members of the firefighters, police and armed forces public service pension schemes).The Finance Act 2022 will also give
0330 161 1234